226 related articles for article (PubMed ID: 23237840)
1. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.
Zitko J; Paterová P; Kubíček V; Mandíková J; Trejtnar F; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2013 Jan; 23(2):476-9. PubMed ID: 23237840
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.
Jandourek O; Tauchman M; Paterova P; Konecna K; Navratilova L; Kubicek V; Holas O; Zitko J; Dolezal M
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157178
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.
Zitko J; Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Hrabcová V; Kuneš J; Soukup O; Doležal M
Molecules; 2013 Dec; 18(12):14807-25. PubMed ID: 24317522
[TBL] [Abstract][Full Text] [Related]
7. Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2014 Jan; 24(2):450-3. PubMed ID: 24388809
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides.
Zitko J; Servusová B; Janoutová A; Paterová P; Mandíková J; Garaj V; Vejsová M; Marek J; Doležal M
Bioorg Med Chem; 2015 Jan; 23(1):174-83. PubMed ID: 25438883
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.
Zitko J; Dolezal M; Svobodova M; Vejsova M; Kunes J; Kucera R; Jilek P
Bioorg Med Chem; 2011 Feb; 19(4):1471-6. PubMed ID: 21273083
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
Sriram D; Yogeeswari P; Reddy SP
Bioorg Med Chem Lett; 2006 Apr; 16(8):2113-6. PubMed ID: 16464574
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.
Vergara FM; Lima CH; Henriques Md; Candéa AL; Lourenço MC; Ferreira Mde L; Kaiser CR; de Souza MV
Eur J Med Chem; 2009 Dec; 44(12):4954-9. PubMed ID: 19765866
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimycobacterial activities of pyrazinamide analogs.
Yamamoto S; Toida I; Watanabe N; Ura T
Antimicrob Agents Chemother; 1995 Sep; 39(9):2088-91. PubMed ID: 8540721
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-infective evaluation of 5-amino-N-phenylpyrazine-2-carboxamides.
Zitko J; Franco F; Paterová P
Ceska Slov Farm; 2015; 64(1-2):19-24. PubMed ID: 26084645
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides.
Semelkova L; Konecna K; Paterova P; Kubicek V; Kunes J; Novakova L; Marek J; Naesens L; Pesko M; Kralova K; Dolezal M; Zitko J
Molecules; 2015 May; 20(5):8687-711. PubMed ID: 26007174
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
18. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
19. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial activity of some phthalimide derivatives.
Akgün H; Karamelekoğlu I; Berk B; Kurnaz I; Sarıbıyık G; Oktem S; Kocagöz T
Bioorg Med Chem; 2012 Jul; 20(13):4149-54. PubMed ID: 22633120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]